Effect of oral antihistamine premedication on mivacurium-induced histamine release and side effects

British Journal of Anaesthesia

Volumn 77, Issue 3, 1996, Pages 421-423

  Doenicke, A ^a   Moss, J ^b   Lorenz, W ^c   Mayer, M ^a   Rau, J ^d   Jedrzejewski, A ^a   Ostwald, P ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF CHICAGO   (United States)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Histamine; Histamine, antihistamines; Neuromuscular block, mivacurium; Premedication, dimethindene; Premedication, ranitidine

Indexed keywords

ANTIHISTAMINIC AGENT; DIMETINDENE; HISTAMINE; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; RANITIDINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HEART RATE; HEMODYNAMICS; HISTAMINE BLOOD LEVEL; HISTAMINE RELEASE; HUMAN; ORAL DRUG ADMINISTRATION; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SYSTOLIC BLOOD PRESSURE;

EID: 0029770653     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/77.3.421     Document Type: Article

References (6)

1. Savarese JJ, Ali HH, Basta SJ, Scott RPF, Embree PB, Wastila WB, Abou-Donia MM, Gelb C. The cardiovascular effects of mivacurium chloride (BW B1090U) in patients receiving nitrous oxide-opiate-barbiturate anesthesia. Anesthesiology 1989; 70: 386-394.
2. Savarese JJ, Ali HH, Basta SJ, Embree PE, Scott RPF, Sunder N, Weakly JN, Wastila WB, El-Sayad HA. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
3. Doenicke A, Moss J, Lorenz W, Hoernecke R, Gottardis M. Are hypotension and rash after atracurium really caused by histamine release? Anesthesia and Analgesia 1994; 78: 967-972.
4. Lorenz W, Neugebauer E. Current techniques of histamine determination: fluorometric assays. In: Uvnäs B, ed. Histamine and Histamine Antagonists (Handbook of Experimental Pharmacology), vol. 97. Berlin: Springer Verlag, 1991; 385-439.
5. Doenicke A, Moss J, Lorenz W, Hoernecke R. Morphine iv and nalbuphine iv cause histamine and catecholamine increase without relevant hemodynamic changes. Clinical Pharmacology and Therapeutics 1995; 58: 81-89.
6. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. Journal of the National Cancer Institute 1959; 22: 719-748.